Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Liver Disease

We would like to thank Mr. Guo and colleagues for their discerning interest and insightful comments on our paper [(1)][1]. First, they mentioned the lack of data on the time in therapeutic range (TTR) in the warfarin group in our study. Unfortunately, this is an inherent limitation of the real-world